What is CCS Associates?
CCS Associates, Inc. (CCSA) is a woman-owned, small business established in 1985 by Dr. Caroline C. Sigman. The firm specializes in providing advanced scientific advisory services across pharmaceutical and device discovery and development. CCSA offers technical and support services for clinical research, designs strategies for preclinical studies, and excels in chemical information sciences and research and development support for translational science. The company has made notable contributions to bioinformatics, developing master databases of chemical information, and collaborates with government and private industry clients to leverage nonclinical and clinical data for pharmaceutical development.
How much funding has CCS Associates raised?
CCS Associates has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in CCS Associates
PPP
Public-Private Partnership
What's next for CCS Associates?
The recent major strategic investment into CCS Associates signals a period of accelerated growth and potential expansion. This capital infusion is likely to fuel further advancements in their scientific advisory services, particularly in the pharmaceutical and biotech sectors. The company's focus on bioinformatics and data management positions it to capitalize on the increasing demand for data-driven insights in drug discovery and development. Future endeavors may include broadening their client base, enhancing their technological capabilities, and forging new strategic partnerships to solidify their market leadership.
See full CCS Associates company page
